Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis. (Q53347361)

13 May 2018

title

Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis. (English)

1 reference

13 May 2018

main subject

chronic myeloid leukemia

0 references

1 reference

13

1 reference

13 May 2018

author name string

Zheng C

1

1 reference

13 May 2018

Li L

2

1 reference

13 May 2018

Haak M

3

1 reference

13 May 2018

Brors B

4

1 reference

13 May 2018

Frank O

5

1 reference

13 May 2018

Giehl M

6

1 reference

13 May 2018

Fabarius A

7

1 reference

13 May 2018

Schatz M

8

1 reference

13 May 2018

Weisser A

9

1 reference

13 May 2018

Lorentz C

10

1 reference

13 May 2018

Gretz N

11

1 reference

13 May 2018

Hehlmann R

12

1 reference

13 May 2018

Seifarth W

14

1 reference

13 May 2018

publication date

1 June 2006

1 reference

13 May 2018

published in

Leukemia

1 reference

13 May 2018

volume

20

1 reference

13 May 2018

issue

6

1 reference

13 May 2018

page(s)

1028-1034

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404227

exact match

0 references

cites work

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

The biology of CML blast crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

A census of human cancer genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Chronic myeloid leukemia: a model for oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Comparative gene expression profile of chronic myeloid leukemia cells innately resistant to imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Chronic myelogenous leukemia molecular signature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Variance stabilization applied to microarray data calibration and to the quantification of differential expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

A systematic statistical linear modeling approach to oligonucleotide array experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

A compendium to ensure computational reproducibility in high-dimensional classification tasks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Gene Selection for Cancer Classification using Support Vector Machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Bioconductor: open software development for computational biology and bioinformatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

The emerging role of alemtuzumab in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Overexpression of SOCS-2 in advanced stages of chronic myeloid leukemia: possible inadequacy of a negative feedback mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Structure of the CAMPATH-1 antigen, a glycosylphosphatidylinositol-anchored glycoprotein which is an exceptionally good target for complement lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Effective treatment of a peripheral T-cell lymphoma/lymphoepitheloid cell variant (Lennert's lymphoma) refractory to chemotherapy with the CD-52 antibody alemtuzumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

JunB inhibits proliferation and transformation in B-lymphoid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

JunB gene expression is inactivated by methylation in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Loss of C/EBP alpha cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Decreased expression of CCAAT/enhancer binding protein zeta (C/EBPzeta) in patients with different myeloid diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Restoration of C/EBPα Expression in a BCR-ABL+ Cell Line Induces Terminal Granulocytic Differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

Pathobiology of lymphoid and myeloid blast crisis and management issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

7 January 2021

Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

7 January 2021

The CAMPATH-1 antigen (CDw52)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

7 January 2021

Expression of CD52 on plasma cells in plasma cell proliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

7 January 2021

Anomalous expression of the HLA-DR alpha and beta chains in ovarian and other cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

7 January 2021

Class II-associated invariant chain peptide expression on myeloid leukemic blasts predicts poor clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404227

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404227

1 reference

13 May 2018

PubMed ID

16617318

1 reference

13 May 2018